In Vitro Activity of the New Glycopeptide LY333328 against Multiply Resistant Gram-Positive Clinical Isolates |
| |
| Authors: | Fernando Garcí a-Garrote, Emilia Cercenado, Luis Alcal , Emilio Bouza |
| |
| Affiliation: | Fernando García-Garrote, Emilia Cercenado, Luis Alcalá, and Emilio Bouza |
| |
| Abstract: | ![]()
The in vitro activity of LY333328 was compared with those of vancomycin and teicoplanin against 425 gram-positive clinical isolates, including a variety of multiply resistant strains. LY333328 at ≤4 μg/ml inhibited all microorganisms tested, including methicillin- and teicoplanin-resistant staphylococci, glycopeptide-resistant enterococci, penicillin- and multiply resistant pneumococci, and viridans and beta-hemolytic streptococci. |
| |
| Keywords: | |
|
|
